M.K. Mohamed

1.1k total citations
21 papers, 835 citations indexed

About

M.K. Mohamed is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M.K. Mohamed has authored 21 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Hepatology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M.K. Mohamed's work include Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (10 papers). M.K. Mohamed is often cited by papers focused on Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (10 papers). M.K. Mohamed collaborates with scholars based in Egypt, France and United States. M.K. Mohamed's co-authors include Arnaud Fontanet, Michel Garenne, José Guerra, Nabiel Mikhail, Maged El‐Setouhy, Ebenezer Israel, Gamal Esmat, Fatma Abdel-Aziz, Mohamed Abdel‐Hamid and Claire Rekacewicz and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Gut.

In The Last Decade

M.K. Mohamed

20 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.K. Mohamed Egypt 13 581 533 63 57 51 21 835
Argemiro D’Oliveira Brazil 15 134 0.2× 318 0.6× 47 0.7× 69 1.2× 19 0.4× 26 766
Fulvio Mozzi Italy 17 964 1.7× 1.4k 2.6× 99 1.6× 85 1.5× 15 0.3× 26 1.7k
Sebastián Marciano Argentina 17 627 1.1× 564 1.1× 48 0.8× 30 0.5× 19 0.4× 82 890
Janaína Luz Narciso-Schiavon Brazil 18 678 1.2× 680 1.3× 29 0.5× 68 1.2× 38 0.7× 83 966
Peter Jarčuška Slovakia 18 432 0.7× 490 0.9× 17 0.3× 22 0.4× 26 0.5× 82 915
Ting‐Yi Chen United States 5 144 0.2× 239 0.4× 55 0.9× 14 0.2× 53 1.0× 5 742
Roongruedee Chaiteerakij Thailand 19 401 0.7× 442 0.8× 10 0.2× 108 1.9× 108 2.1× 64 1.1k
Martin Janíčko Slovakia 14 347 0.6× 391 0.7× 11 0.2× 20 0.4× 21 0.4× 60 638
Hans Hsienhong Lin Taiwan 21 839 1.4× 951 1.8× 18 0.3× 32 0.6× 38 0.7× 53 1.2k
Claudia Martorell United States 14 629 1.1× 598 1.1× 29 0.5× 129 2.3× 9 0.2× 28 1.3k

Countries citing papers authored by M.K. Mohamed

Since Specialization
Citations

This map shows the geographic impact of M.K. Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.K. Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.K. Mohamed more than expected).

Fields of papers citing papers by M.K. Mohamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.K. Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.K. Mohamed. The network helps show where M.K. Mohamed may publish in the future.

Co-authorship network of co-authors of M.K. Mohamed

This figure shows the co-authorship network connecting the top 25 collaborators of M.K. Mohamed. A scholar is included among the top collaborators of M.K. Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.K. Mohamed. M.K. Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohamed, M.K., Marwa M. Khalaf, Amira M. Abo‐Youssef, & Ali A. Abo‐Saif. (2017). CAFFEINEAS A PROMISING ANTIFBROTIC AGENT AGAINST CCL4-INDUCED LIVER FIBROSIS. International Journal of Pharmacy and Pharmaceutical Sciences. 9(6). 42–42. 2 indexed citations
2.
Breban, Romulus, Naglaa Arafa, Sandrine Leroy, et al.. (2014). Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study. The Lancet Global Health. 2(9). e541–e549. 32 indexed citations
3.
Mohsen, Amira, Adeline Bernier, Elisabeth Delarocque‐Astagneau, et al.. (2014). Hepatitis C virus acquisition among Egyptians: analysis of a 10‐year surveillance of acute hepatitis C. Tropical Medicine & International Health. 20(1). 89–97. 26 indexed citations
4.
Guerra, José, Michel Garenne, M.K. Mohamed, & Arnaud Fontanet. (2012). HCV burden of infection in Egypt: results from a nationwide survey. Journal of Viral Hepatitis. 19(8). 560–567. 164 indexed citations
5.
Vignier, Nicolas, Gamal Esmat, Mohamed Hassany, et al.. (2011). Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)‐infected patients in Egypt. Journal of Viral Hepatitis. 18(7). e358–65. 11 indexed citations
6.
Mohamed, M.K., et al.. (2010). Relationship between HCV infection and Insulin resistance in non-obese non- diabetic patients. The Egyptian Journal of Hospital Medicine. 41(1). 540–550.
7.
8.
Mostafa, Aya, M.K. Mohamed, Arnaud Fontanet, et al.. (2010). Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut. 59(8). 1135–1140. 101 indexed citations
9.
El‐Setouhy, Maged, Christopher A. Loffredo, Ghada Nasr Radwan, et al.. (2008). Genotoxic effects of waterpipe smoking on the buccal mucosa cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 655(1-2). 36–40. 68 indexed citations
10.
Esmat, Gamal, Claire Rekacewicz, Khaled Zalata, et al.. (2007). Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C.. PubMed. 12(5). 797–803. 40 indexed citations
11.
Stoszek, Sonia, Samy Selim, Asrul Abdul Wahab, et al.. (2006). Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile Delta. Clinical Infectious Diseases. 42(5). 628–633. 53 indexed citations
12.
Israel, Ebenezer, et al.. (2006). Evaluation of Papanicolaou Stain for Studying Micronuclei in Buccal Cells Under Field Conditions. Acta Cytologica. 50(4). 398–402. 26 indexed citations
13.
Arafa, Naglaa, Claire Rekacewicz, Iman Bakr, et al.. (2005). Changing pattern of hepatitis C virus spread in rural areas of Egypt. Journal of Hepatology. 43(3). 418–424. 88 indexed citations
14.
Gaafary, Maha El, Claire Rekacewicz, Mohamed Farouk Allam, et al.. (2005). Surveillance of acute hepatitis C in Cairo, Egypt. Journal of Medical Virology. 76(4). 520–525. 39 indexed citations
15.
Mohamed, M.K., Mohamed Abdel‐Hamid, Nabiel Mikhail, et al.. (2005). Intrafamilial Transmission of Hepatitis C in Egypt *. Hepatology. 42(3). 683–687. 97 indexed citations
16.
Gadalla, Shahinaz M., Maged El‐Setouhy, Nabiel Mikhail, et al.. (2003). Prevalence of smoking among rural secondary school students in Qualyobia governorate.. PubMed. 33(3 Suppl). 1031–50. 40 indexed citations
17.
El‐Setouhy, Maged, Shahinaz M. Gadalla, Fatma Abdel-Aziz, et al.. (2003). Nicotine dependance among adult male smokers in rural Egypt.. PubMed. 33(3 Suppl). 1019–30. 6 indexed citations
18.
Esmat, Gamal, M.K. Mohamed, Khaled Zalata, et al.. (2003). The impact of steatosis on baseline characteristic and end of treatment response for chronic hepatitis (C) genotype 4 patients treated with interferon. Journal of Hepatology. 38. 139–139. 7 indexed citations
19.
Blaauboer, Bas J., Michael Balls, Martin D. Barratt, et al.. (1998). 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies and conceptual issues.. Environmental Health Perspectives. 106(suppl 2). 413–418. 24 indexed citations
20.
Blaauboer, Bas J., Michael Balls, Martin D. Barratt, et al.. (1998). Joint Reports 13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): Alternative Testing Methodologies and Conceptual Issues. Environmental Health Perspectives. 106. 413–413. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026